SCHEMBL25009807

SCHEMBL25009807

c1cc2nc(c1)CNCc1cccc(n1)CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 4/20 0.47
ADRB1 P08588 1/20 0.35
HTR2A P28223 2/20 0.32
HTR2C P28335 1/20 0.32
SLC6A4 P31645 1/20 0.32
HTR3E A5X5Y0 1/20 0.31
HTR3B O95264 1/20 0.31
CYP1A2 P05177 1/20 0.31
HTR1A P08908 1/20 0.31
CYP2D6 P10635 1/20 0.31
NCF1 P14598 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
HTR1D P28221 1/20 0.31
HTR1B P28222 1/20 0.31
HTR7 P34969 1/20 0.31
MTOR P42345 1/20 0.31
HTR3A P46098 1/20 0.31
HTR5A P47898 1/20 0.31
HTR6 P50406 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13495066 0.92 CXCR4 (0.52) CXCR4ADRB1HTR2AHTR2CSLC6A4
SCHEMBL9207672 0.82 CXCR4 (0.58) CXCR4ADRB1HTR2AHTR2CSLC6A4
SCHEMBL8235408 0.80 CXCR4 (0.56) CXCR4ADRB1HTR2AHTR2CSLC6A4
SCHEMBL29520740 0.80 CXCR4 (0.56) CXCR4ADRB1HTR2AHTR2CSLC6A4
SCHEMBL13566517 0.80 CXCR4 (0.43) CXCR4ADRB1HTR2AHTR2CSLC6A4
SCHEMBL1673295 0.80 CXCR4 (0.56) CXCR4ADRB1HTR2AHTR2CSLC6A4
SCHEMBL31649015 0.76 CXCR4 (0.53) CXCR4ADRB1HTR2AHTR2CSLC6A4
SCHEMBL16942426 0.76 CXCR4 (0.45) CXCR4ADRB1HTR2AHTR2CSLC6A4
SCHEMBL14206482 0.73 CXCR4 (0.50) CXCR4ADRB1HTR2AHTR2CSLC6A4
SCHEMBL14274068 0.73 CXCR4 (0.38) CXCR4TSHRHSD17B10KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827653-B2 Tridentate macrocyclic compounds THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2023-11-28 US disclosed
US-11827653-B2 Tridentate macrocyclic compounds THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2023-11-28 US disclosed
US-20230040709-A1 TRIDENTATE MACROCYCLIC COMPOUNDS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040709-A1 TRIDENTATE MACROCYCLIC COMPOUNDS CBR3, NOX3, CYB5R3 CXCR4 3710/4885ADRB1 3612/4885HTR2A 4347/4885
US-11827653-B2 Tridentate macrocyclic compounds CBR3, NOX3, CYB5R3 CXCR4 3710/4885ADRB1 3612/4885HTR2A 4347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.